The Ets family of transcription factors comprises several members which are involved to regulate gene transcription. Although several consensus binding sites for Ets proteins can be found in a wide series of promoter, only a limited number of them are indeed activated by these transcription factors. The human intercellular adhesion molecule-1 (ICAM-1) plays a crucial role in immune responses by enabling the binding of eector cells to various target cell types. ICAM-1 is constitutively expressed at dierent levels in the absence of stimuli in dierent cell types, and its expression is upregulated by several proin¯ammatory cytokines. We have here examined the transcriptional regulation of human ICAM-1 expression by Ets proteins, and more particularly by ERM, a member of this family of transcription factors. Transient transfection assays revealed that Ets-2 and ERM signi®cantly activate the transcription of ICAM-1 promoter, whereas the less-related Ets family member, Spi-1/Pu.1, failed to do so. Transfection of a series of ICAM-1 promoter deletion mutants together with ERM expression plasmids have shown that an Ets responsive element is located within the ®rst 176 bp upstream from the translational start site. Electrophoretic mobility shift assays and DNase I footprinting analysis have enabled us to identify two Ets binding sites at positions 7158 and 7138 from the ATG, respectively. Site directed mutagenesis of these elements has shown that the distal site is the major element required for the ERM-mediated activation of the ICAM-1 promoter. We can thus conclude that expression of ICAM-1 can be regulated by Ets transcription factors.
Introduction
The Ets family of transcription factors is an ubiquitously expressed group of proteins involved to regulate gene transcription in normal and cancerous tissues as well as during embryonic development. The hallmark of these transcription factors is a DNAbinding domain ± the ETS domain ± of &85 amino acids (Karim et al., 1990) , which recognizes the core sequence GGAA/T, present in the regulatory region of a wide array of responsive genes, including membrane receptors, growth factors, transcription factors, and extracellular metalloproteinases (Wasylyk et al., 1993; Janknecht and Nordheim, 1993; CreÂ pieux et al., 1994) . The Ets family comprises several members classi®ed into dierent groups with respect to their sequence homology within the ETS domain. The PEA3 group (for review, see de Launoit et al., 1997) is composed of three members: PEA3 (Xin et al., 1992; Higashino et al., 1993) , ER81 (Brown and McKnight, 1992; Jeon et al, 1995; MonteÂ et al., 1995) and ERM (MonteÂ et al., 1994) . These three factors share more than 95% identity within the ETS domain (MonteÂ et al., 1994) .
The human intercellular adhesion molecule-1 (ICAM-1, CD54), a member of the immunoglobulin supergene family, is an adhesion receptor of the immune system which mediates antigen-independent cell-cell contact between eector cells expressing the b2-integrin molecules LFA-1 and Mac-1, and target cells of various origins (Rothlein et al., 1986; Marlin and Springer, 1987; Diamond et al., 1990) . Interaction between LFA-1 or Mac-1 and ICAM-1 is essential for immune responses. For instance, it increases the avidity of the interaction between the T-cell receptor and antigen presented in the context of class II MHC molecules (Altman et al., 1989) . ICAM-1-b2-integrin interaction is also required for T-cell cytotoxicity, and leukocyte tracking and migration into in¯amed tissues (for review, see Dustin et al., 1988; Albelda et al., 1994) . ICAM-1 expression is regulated by in¯ammatory mediators such as tumor necrosis factor-a (TNFa), interleukin-1b (IL-1b), interferon-g (IFNg), as well as by bacterial liposaccharide, phorbol esters and retinoic acid (RA) (for review, see Stratowa and Audette, 1995 and references therein) . The stimulation of the ICAM-1 protein expression correlates with increased levels of ICAM-1 mRNA, thus suggesting that ICAM-1 expression could occur at the transcriptional level (Simmons et al., 1988) .
The 5'-regulatory region of the human ICAM-1 gene has been cloned and characterized (Stade et al., 1990; Voraberger et al., 1991; Wawryk et al., 1991) , and two transcriptional start sites have been mapped, respectively 41 bp and 319 bp upstream from the translational start site (Voraberger et al., 1991) . The analysis of the 6 kb-region upstream from the ATG indicated the presence of one silencing and four enhancing elements contributing to the constitutive promoter activity (Jahnke et al., 1995) . Deletion mutant analyses of the 5'-regulatory region of the ICAM-1 gene demonstrated the crucial role of the TATA-box located at position 770, 30 bp upstream from the proximal start site. Several responsive elements for binding transcription factors have been identi®ed in the promoter region of the ICAM-1 gene. Indeed, ICAM-1 is regulated by RA in an RA receptor-b/retinoid X receptor-a-dependent fashion through an RA response element (RARE) located at position 7266 (Aoudjit et al., 1994 (Aoudjit et al., , 1995 . The NF-kB binding site situated at position 7228, which binds p65 homodimers as well as p65/p50 and p65/c-rel heterodimers (Hou et al., 1994; Ledebur and Parks, 1995; Aoudjit et al., 1997) is essential for TNFa and IL-1b induction (Voraberger et al., 1991; Ledebur and Parks, 1995; Aoudjit et al., 1997) . A palindromic sequence present at position 7116 was identi®ed as an IFNg activating site recognized by p91/STAT1 (Caldenhoven et al., 1994) .
The ICAM-1 promoter also harbors several GGAA/ T motifs, the core sequence for binding the Ets family of transcription factors. However, very little is known about the possible regulation of the ICAM-1 gene by transcription factors from the Ets family which regulate the transcription of a wide variety of genes (for review, see CreÂ pieux et al., 1994) . Recently, an H 2 O 2 -responsive element was identi®ed between nucleotides 7981 and 7769, a region which was found to harbor an AP-1/Ets composite element. However, neither the induction of Ets or AP-1 family members by H 2 O 2 , nor their binding to the composite element have been demonstrated (Roebuck et al., 1995) .
In an investigation of the role of Ets transcription factors in the regulation of ICAM-1, we found that Ets-2 and ERM dramatically activate ICAM-1 transcription in mammalian cells. An Ets-binding site was mapped to position 7158, which was largely responsible for the ERM-mediated activation of gene transcription. Finally, we showed that mutation of this site resulted in decreased transcriptional activity and abrogated ERM binding.
Results

Activation of the human ICAM-1 promoter by Ets proteins
Transient transfection assays were performed in RK13 rabbit kidney cells to determine whether Ets proteins transactivate the ICAM-1 promoter. As shown in Figure 1a , Ets-2 and ERM activated the pBHluc1.3 reporter plasmid by 6.7-and 9.5-fold respectively. In contrast, the Spi-1/Pu.1 Ets transcription factor was unable to increase the transactivation. To con®rm that Spi-1/Pu.1 is functional in RK-13 cells, the reporter plasmid containing the Ets-binding site of the fes promoter was cotransfected with the Ets expression plasmids. As shown in Figure 1b , Ets-2, ERM and Spi-1/Pu.1 activated the fes transcription 14.3-, 17.2-and 19.0-fold respectively. This indicates that the Ets proteins such as Ets-1 (data not shown), Ets-2, PEA3 (data not shown) and ERM are able to activate the human ICAM-1 promoter, whereas the less-related Ets family member, Spi-1/Pu.1, which is a transactivating factor in RK13 cells, failed to activate this promoter.
Transient transfection assays were performed in JEG-3 human choriocarcinoma and RK13 rabbit kidney cells to localize Ets binding site(s) in the ICAM-1 promoter. Luciferase activity driven by the ICAM-1 promoter and some deletion mutants is reported in Table 1 . The basal activation level of pBHluc1.3 reporter plasmid transfected with pSG5 vector was referred to one in both cell lines. In JEG-3 cells, the reporter plasmids B, C, E and N exhibited almost the same basal transactivation level as that of pBHluc1.3, whereas plasmid D activation was 3.7-fold higher. The transcriptional activity of ICAM-1 promoter reporter plasmids pBHluc1.3, B, C, D and E was strongly stimulated 49.6-, 31.9-, 38.7-and 34.9-fold respectively upon the transfection of the ERM expression plasmid. Plasmid N was stimulated 6.9-fold. In the RK13 cells, the basal activity of the ICAM-1 promoter and its deletion mutants B, C, D was virtually the same, whereas that of plasmids E and N was 30% and 10% of the pBHluc1.3 level. ERM also stimulated the transcriptional activity of the ICAM-1 promoter reporter constructs, although RK13 are less responsive than JEG-3 cells. Indeed, .7-fold increase were obtained with plasmids pBHluc1.3 and B, C, D and E respectively, whereas plasmid N did not respond to ERM. These results indicate that the main ERM responsive element(s) is(are) located within the ®rst 176 bp upstream from the ATG.
We have recently shown that ERM contains two transactivation domains respectively at the N-terminal (a) and the C-terminal (Ct) domains that act synergistically on arti®cial Ets responsive elements (Laget et 1996; Janknecht et al., 1996) . Here, we examined whether these two domains were required for ICAM-1 promoter transactivation. We thus used the E reporter plasmid to compare the transactivation capacities of dierent truncated ERM proteins ( Figure 2a ). As illustrated in Figure 2b , the relative luciferase activity measured from the E reporter increased 32.4-and 4.8-fold in JEG-3 and RK13 cells transfected with the plasmid encoding the full-length ERM (ERM 1 ± 510 ), respectively as compared to cells transfected with the pSG5 plasmid as control. The transactivation observed in JEG-3 transfected with the plasmids encoding for the ERM 87 ± 510 and ERM 355 ± 510 truncated proteins, both of which lack the ®rst 87 amino acids, increased 6.1-and 14.8-fold, respectively, as compared to the transactivation induced by pSG5 plasmid alone. In RK13 cells, the corresponding transactivation levels were 1.9 and 1.0, respectively. The construct encoding the ERM 1 ± 449 truncated protein, which only lacks the Ct domain, transactivated less than the full-length ERM, although it still retains a signi®cant degree of transactivation activity. In fact, in JEG-3 and RK13 cells the ERM 1 ± 449 truncated protein stimulated 14.8-and 2.8-fold the transactivation on the E reporter plasmid, respectively, as compared to the pSG5 plasmid alone. In both cell lines transfected with ERM 87 ± 449 expression plasmids, which lack both transactivation domains, the transactivation level was not over the basal value ( Figure 2b ). These data thus indicate that in the context of the 7176 to 744 region of the ICAM-1 promoter, ERM activates gene transcription through two transactivation domains corresponding to the amino-terminal and carboxy-terminal domains.
In vitro mapping of the Ets binding sites within the 7178 to 744 region of the ICAM-1 promoter
As illustrated in Figure 3a , the region of the ICAM-1 promoter corresponding to the WT-bas plasmid (7178 to 744 bp upstream from the translation start site) contains several putative Ets binding sites Reporter plasmid pBHluc1.3 containing the ICAM-1 promoter as well as deletion mutant plasmids B, C, D, E, and N (Voraberger et al., 1991) were cloned upstream from the luciferase gene. The endpoints of fragments are numbered relative to the translation start site (A from ATG=+1). Two hundred thousand rabbit RK13 kidney carcinoma or human JEG-3 choriocarcinoma cells were transiently transfected by the lipofectamine technique with 0.2 mg of the indicated luciferase reporter genes in the presence of 0.6 mg of pSG5 expression vector, and 0.2 mg RSV-bGal plasmid. Twenty-four hours later, cellular proteins were collected as described in the Materials and methods section and relative luciferase activity corresponding to each deletion promoter construct in the presence of pSG5 (basal) GGAA. To map the DNA sequences recognized by the ERM 355 ± 510 GST-fusion protein, we performed DNAse I footprinting experiments using an endlabeled DNA probe comprising the region between nucleotides 7178 to 744 (Figure 3b ). We observed two main footprinted regions corresponding to the arrows. At position 7136, the protected nucleotide corresponded to the second C of the TTCC Ets reverse core sequence whereas at position 7155, it corresponded to the second A of the GGAA Ets core sequence. Two hypersensitive nucleotides were also mapped at position 7130 and 7159 (stars) in the vicinity of each of the two protected nucleotides (Figure 3 ). The same results were obtained with the GST-ERM 1 ± 510 fusion protein (data not shown).
We then performed EMSA with labeled doublestranded oligonucleotides covering this region. As shown in Figure 4a , in vitro translated ERM 1 ± 510 protein strongly bound to the 7175 to 7145 region (arrow) but not the three other oligonucleotides corresponding to nucleotides 7210 to 7174, 7150 to 7117 and 7128 to 793. This binding is speci®c since it was displaced by an excess of nonradiolabeled oligonucleotide, whereas an unrelated oligonucleotide did not compete with the binding (data not shown). As a positive control, we showed that ERM bound to the PEA3 MAX oligonucleotide which is recognized by Ets family members (MonteÂ et al., 1994) . Since the 7175 to 7145 region contained the GGAA Ets binding site which is protected at position 7155, we mutated this site in the 7175 to 7145 oligonucleotide by replacing the GG by CC to generate the 7175 to 7145* oligonucleotide. Although ERM bound to the 7175 to 7145 wild-type oligonucleotide, it was unable to bind to the mutated 7175 to 7145* probe (Figure 4b) .
The second protected nucleotide at position 7136 was located within the TTCC Ets reverse core consensus site. EMSA performed with the 7150 to 7117 bp fragment as a probe enabled us to detect a speci®c binding with the GST-ERM 11 ± 510 fused protein (Figure 4c ). However, this binding was weaker than that obtained with the 7175 to 7145 oligonucleotide (data not shown). That we detected a signal on the 7150 to 7117 bp fragment with GST-ERM 11 ± 510 fusion protein and not with the ERM protein produced in reticulocyte lysates was due to the dierent amounts of protein produced and could indicate that this site only has a weak anity for ERM. As indicated in Figure 4c by competition experiments, the speci®c binding between GST-ERM 11 ± 510 fused protein and the 7175 to 7145 or the 7150 to 7117 probes is strongly competed by the 7175 to 7145 unlabeled primer. This is illustrated by the data showing that the 50-fold-excess of this unlabeled primer dramatically reduce the binding observed with both probes. In contrast, although excess of the 7150 to 7117 unlabeled primer decrease the binding of both probes, this displacement eect is at least fourfold less intense than with the 7175 to 7145 unlabeled primer. These data suggest that the GGAA and the TTCC sites located in the ICAM-1 promoter at positions 7158 and 7138, respectively are the Ets binding sites which might be responsible for the activation of this promoter by ERM, although the 7175 to 7145 site seems to be the site which the highest anity for this transcription factor.
Mutation of the Ets binding site at position 7158 of the ICAM-1 promoter diminishes ICAM-1 gene transcription
To determine whether both Ets binding sites at positions 7158 and 7138 are transcriptionally DNAse I footprinting was performed as described (Plaza et al., 1995a,b) . Two ng of the end-labeled HindIII ± XbaI restriction fragment of the WT plasmid (nucleotide 7178 to 744 of the ICAM-1 promoter) was incubated in the presence or absence of GST or GST-ERM 355 ± 510 fusion protein followed by digestion with DNAse I. After extraction, the samples were precipitated and analysed on 6% polyacrylamide sequencing gel before autoradiography for 24 h. Footprints were calibrated with Maxam and Gilbert (lane G+A). The two main protected nucleotide regions are indicated by arrows, and the two main hypersensitive nucleotides by stars. The nucleotide sequences corresponding to the protected regions are presented on the left We then tested in RK13 cells, previously characterized in our group relatively to its Ets-dependent transcriptional activity, whether the 7158 site is activated by the endogenous Ets proteins. As illustrated in Figure 5 , the basal transactivation level obtained with the MUT 158 reporter plasmid was twofold lower than that obtained with the control plasmid. In contrast, the transactivation level obtained with the MUT 138 reporter plasmid was similar to that obtained with the control plasmid (WT), whereas the level obtained with the MUT 158 ± 138 reporter plasmid was identical to that with the MUT 158 reporter plasmid ( Figure 5 ). This experiment shows that the Ets-binding site located at position 7158 is the major functional Ets binding site of the ICAM-1 promoter and demonstrates that endogenous Ets proteins contribute to the basal activity of the ICAM-1 promoter.
Results obtained with these reporter plasmids in cotransfection with ERM are reported in Figure 6 . ERM increased WT-bas transactivation in JEG-3 and RK13 cells 25.2-and 5.7-fold, respectively. In contrast, when MUT 158 was used as the reporter plasmid, the transactivation induced by ERM was only 6.1-and 1.2-fold in JEG-3 and RK13 cells respectively. The mutation of the second Ets site at position 7138 reduced the transactivation induced by ERM significantly but less eciently, since it increased MUT 138 plasmid transactivation in the JEG-3 and RK13 cells 17.4-and 2.2-fold, respectively. This re¯ects the relative anity of ERM for this latter site and supports the results obtained in EMSA (Figure 4) The arrow corresponds to the protein-DNA complex and the free probe is not shown. The relative DNAbinding anities were appreciated with increasing amounts of one of the two unlabeled double stranded primers. The primer excess varies from 50-to 300-fold Figure 5 Constitutive transactivation on wild-type or mutant ICAM-1 promoter. The RK13 cells were transfected as described in Table 1 with 0.6 mg of the pSG5 vector, 0.2 mg RSV-bGal vector and 0.2 mg of the wild-type (WT) or mutant 7178 to 744 ICAM-1 promoter-pGL2 reporter plasmids described in Figure 6 . The data obtained on four independent experiments with three dierent plasmid preparations are presented as fold activation with respect to the WT-bas reporter plasmid (100%) reduce ERM-induced transactivation any further ( Figure 6 ). Taken together, these data clearly indicate that the Ets binding site located at position 7158 of the human ICAM-1 promoter is mainly responsible for the ERM-mediated increase in transcriptional activity.
Discussion
We demonstrate here that members of the Ets family of transcription factors can play a role in human ICAM-1 gene regulation by identifying a functional Ets binding site in the ICAM-1 promoter. The ICAM-1 promoter (Voraberger et al., 1991) contains several GGAA/T motifs, the cognate DNA sequence for the binding of Ets proteins (for review see, CreÂ pieux et al., 1994) . In the present study, we demonstrate that the Ets proteins Ets-1 (data not shown), Ets-2, ER81, PEA3 (data not shown) and ERM strongly activate the ICAM-1 promoter, whereas the myeloid speci®c Ets protein, Spi-1/Pu.1, did not activate this promoter. That Spi-1/Pu.1 does not transactivate the ICAM promoter can be explained by its more distant relationship with the other Ets family members (Laudet et al., 1993) . Although most of the Ets proteins have the ability to bind the GGAA/T cores sequence,¯anking nucleotides are important to speci®cally optimize the binding of certain Ets family members. The ICAM-1 Ets binding site identi®ed here signi®cantly diverges from that described to optimize Spi-1/Pu.1 binding (Ray-Gallet et al., 1995) .
Whereas the truncation of plasmid pBHluc1.3 to give plasmids B, C, D and E resulted in variations in their respective basal transcriptional activity, their responsiveness to ERM remained roughly the same in both the JEG-3 and the RK13 cells. This observation suggested that the region by which ERM acts directly or indirectly in ICAM-1 activation mapped between position 7176 and 744. Several putative Ets binding sites are present in this region, two of which were found to bind ERM. In fact, we con®rmed that the 7193 putative Ets binding site identi®ed by Ledebur and Parks (1995) was non-functional, whereas the 7158 and 7138 Ets binding sites were identi®ed by two independent methods as the DNA motifs responsible for direct interaction with ERM. With respect to the ability of ERM to bind speci®cally to the PEA3 MAX (MonteÂ et al., 1995) sequence derived from the polyomavirus enhancer, gel shift analysis enabled us to identify a high anity Ets binding site at position 7158 and a lower anity one at position 7138 by means of bacterially expressed ERM protein.
DNAse footprinting experiments enabled us to determine that the ®rst G from the GGAA motif at position 7155 is protected, as is the second G of the inverse Ets motif at position 7136. These two protected sequences present both hypersensitive sites at C 159 and G 130 . The recent elucidation of the structure of the ETS domain-DNA complex is understood in terms of steric interference with the extensive contacts formed by helix H3 of the ETS domain with GG in the major groove (Werner et al., 1995) . The speci®city of a particular promoter response element for a given Ets family member is determined by the nucleotide sequence¯anking the core GGAA/T motif. These sequences are 5'-TCCGGAAATA-3' around site 7155 and 5'-TCCGGAACAA-3' around site 7136. Both sequences were recovered by target detection assay with several Ets proteins such as ER81, which is the closely ERM-related Ets protein (Brown and McKnight, 1992) .
The mutation of the Ets binding site at position 7158 abrogated the binding to both the ERM and the other Ets proteins (data not shown), and decreased the ERM-mediated transactivation of the WT-bas plasmid. However in the JEG-3 cells, this mutation did not completely abolish the ERM-dependent eect. Moreover, the 7150 to 744 promoter region was still able to be slightly activated by ERM, thus suggesting that other sequences in this region are involved in the Etsmediated regulation of ICAM-1 gene in JEG-3 cells. ERM may indeed regulate the transcription of other transactivating factors, binding downstream position 7150, to upregulate ICAM-1 gene transcription. This remains to be elucidated.
Transient transfection experiments were carried out in two cell types: JEG-3 cells do not contain PEA3 group member mRNA (MonteÂ et al., 1994 (MonteÂ et al., , 1995 , whereas RK13 cells do contain signi®cant amount of at least ERM proteins as assessed by immunoprecipitation (data not shown). This thus explains the high level of induction by ERM in JEG-3 cells as compared to RK13. The human choriocarcinoma JAR cell line which does not express PEA3 group members has been similarly tested and high level of induction by cotransfected ERM has also been obtained (data not shown).
To further investigate the biological relevance of the Ets-mediated increased ICAM-1 gene promoter activity, we have tested whether endogenous Ets indeed contribute to the basal activity of the ICAM-1 Figure 6 ERM-mediated transactivation on wild-type or mutant ICAM-1 promoter. The JEG-3 and RK13 cells were transfected as described in Table 1 and Figure 1 with 0.6 mg of the expression vectors (pSG5 or pSG5-ERM), 0.2 mg RSV-bGal vector and 0.2 mg of the wild-type (WT) or mutant 7178 to 744 ICAM-1 promoter-pGL2 reporter plasmids. The MUT 158 -bas or MUT 138 -bas recombinant plasmids were mutated in the two Ets binding sites by replacing the GG of the GGAA core sequence by CC at position 7158 (MUT 158 ) or the CC of the TTCC core sequence by GG at position 7138 (MUT 138 ). The MUT 158 ± 138 -bas (MUT 158 ± 138 ) recombinant plasmid corresponds to the double mutant. The data obtained on two independent experiments with three dierent plasmid preparations are presented as fold activation with respect to the pSG5 control plasmid alone promoter. Disruption of the site at position 7158 signi®cantly decreased by 50% the basal activity of the promoter in RK13 cells.
Since ERM and Ets-2 (data not shown) activate the ICAM-1 promoter through the Ets binding site at position 7158, this thus indicates that cofactors putatively required for Ets activity are present in these cell lines RK13 and JEG-3 cells. We showed here that on a constitutive basis, ICAM-1 gene can be regulated by several Ets family members. Whether they contribute to optimize the cytokine-mediated increased ICAM-1 gene transcription remains to be determined. Cooperative functions between speci®c Ets family members and other DNA-binding proteins are important to optimize gene expression. This was shown for instance for Ets-1 and Ets-2, which functionally cooperate with c-Fos and c-Jun to activate transcription from the Ets-AP1 motif present in the polyoma virus enhancer . Moreover, a direct physical interaction between Ets and AP-1 proteins has been demonstrated (Bassuk and Leiden, 1995, and references therein) . Although ERM can act synergistically with c-Jun for optimal Ets-binding site activation (Nakae et al., 1995) , the 7176 to 744 region of the ICAM-1 promoter does not contain any consensus AP-1 site. The ®rst imperfect consensus AP-1 site is in fact located at position 7324, which is not included in deletion reporter plasmid E, and therefore rules out a putative cooperation between ERM and cJun/c-Fos in the context of the ICAM-1 transcription (Table 1) . We thus co-transfected ERM or Ets-2 with cJun and c-Fos expression plasmids and no signi®cant increase in reporter transactivation was observed (data not shown). Thus, it seems that ICAM-1 regulation by the Ets proteins tested is independent of the other transcription factors currently characterized.
The Ets proteins are implicated in metastatic spreading as transcriptional regulators of the metalloproteinases (MMP) stromelysin I, and type I and IV collagenases (Gutman and Wasylyk, 1990; Wasylyk et al., 1991; Sato and Seiki, 1993) . It was recently demonstrated in human cells that the closely ERMrelated factor PEA3 (EIA-F) is able to activate these latter three genes (Higashino et al., 1993) . Moreover, when PEA3 is over-expressed in the MCF-7 mammary cancer cells, the endogenous MMP 92 kDa type IV collagenase is upregulated. Altogether, these results provide evidence of an important role for Ets-related transcription factors, and more particularly the PEA3 group members, in tumor cell invasion. Strong ICAM-1 expression is found in solid tumors such as melanomas and renal carcinomas and in a lesser extent in gastric, breast and colorectal carcinomas (Vogetseder et al., 1989; Natali et al., 1990; Johnson, 1991) . As far as melanoma are concerned, de novo ICAM-1 expression correlates with increased risk of metastasis (Johnson et al., 1989) . This suggests that the regulation of ICAM-1 gene by Ets proteins, particularly the PEA3 group members, might be linked through its co-regulation with MMPs during the metastasis process, and so might enable melanoma cells to invade the adjacent tissue and then to disseminate. Similarly, Ets family members might also contribute to co-regulating adhesion molecule and protease expression in in¯amed joints associated with tissue destruction.
Materials and methods
Expression and reporter vectors
The ERM 87 ± 510 , ERM 355 ± 510 , ERM 1 ± 449 and ERM 87 ± 449 truncated proteins were generated by PCR and subcloned into the pSG5 expression vector as described (Janknecht et al., 1996) . Plasmid pBHluc1.3 harboring the ICAM-1 promoter, and promoter constructs inserted upstream from the luciferase gene, have been previously described (Voraberger et al., 1991) and were kindly provided by Dr C Stratowa, Bender+Co, Vienna, Austria. ICAM-1 promoter region mapping between positions 7178 to 744 was ampli®ed by PCR using the 5'-CCCGGGCACCCTGT-CAGTCCGGAAATAACTGCA-3' upstream and the 5'-GTCGACTGGGGCGCGTGATCCTTTATAGCGCTA-3' downstream primers, and was cloned into the PCRII vector (InVitrogen, San Diego, CA), to generate the WT-PCRII plasmid. WT-PCRII was thcn digested with SmaI ± BgIII endonucleases and the resulting fragment was subcloned into the SmaI ± BglII sites of the pGL2-Basic vector (Promega, Madison, Wl), upstream from the luciferase gene, thus leading to the recombinant plasmid WT-bas. The same strategy was employed to speci®cally introduce mutations within the Ets binding sites at positions 7158 and 7138. The upstream primers: 5'-CCCGGGCACC-CTGTCAGTCCCCAAATAACTGCA-3' and 5'-CCCG-GGCACCCTGTCAGTCCGGAAATAACTGCAGCATT-TGTTGGGGAG-3' were used with the above described downstream primer, to obtain MUT 158 -bas and MUT 138 -bas recombinant plasmids respectively. Double Ets mutant MUT 158 ± 138 -bas was also generated by means of the upstream primer: 5'-CCCGGGCACCCTGTCAGTC CCCAAATAACTGCAGCATTTGTTGGGGAG-3'. The pBfes.luc plasmid containing three copies of the 40-mer oligonucleotide corresponding to the Ets-responsive element of the fes promoter (Ray-Gallet et al., 1995) cloned upstream from the luciferase gene was kindly provided by Dr F Moreau-Gachelin (Paris, France). The pSG5-Spi-1/ Pu.1 encoding the chicken Spi-1/Pu.1 open reading frame was kindly provided by Dr Jean Coll (Lille).
Transfection assays
Rabbit kidney carcinoma RK13 (ATCC no CCL37), human choriocarcinoma JEG-3 (ATCC no HTB-36) and JAR (ATCC no HTB-144) cell cultures were routinely maintained in Dulbecco medium with 10% fetal calf serum and kept at 378C in an H 2 O saturated 5% CO 2 atmosphere. Transfections were performed by the lipofectamine procedure (Gibco-BRL, Cergy Pontoise, France) in 35-mm-dishes as described (CreÂ pieux et al., 1993; MonteÂ et al., 1995) . All the assays were normalized to the b-galactosidase activity of the RSV-bGal vector and all the experiments were performed at least twice using at least two dierent plasmid preparations. For each ®gure, we report data obtained from a representative experiment.
Electrophoretic mobility-shift assays (EMSA)
One mg of pSG5-ERM 1 ± 510 plasmid was transcribed with 10 units of T7 RNA polymerase. The resulting ERM RNA was translated in 25 ml of rabbit reticulocyte lysate reaction mixture containing 40 mCi [ 35 S]methionine as speci®ed by the manufacturer (Promega, Madison, WI) for 1.5 h at 308C. Proteins produced in reticulocyte lysates or in bacteria were incubated for 1 h on ice in a ®nal volume of 20 ml with 20 mM HEPES pH 7.9, 20% v/v glycerol, 0.1 mM EDTA, 1 mM DTT, 1 mg/20 ml poly (dI : dC), 50 mM NaCl and end-labeled double-stranded oligo-nucleotide probe comprising the Polyomavirus enhancer sequence 5' -GATCTTCGAAAGGAAGTTC-GAG-3' (PEA3 MAX ) (MonteÂ et al., 1994) or the ICAM-1 promoter sequences: 5'-AGCGGCCAGCGAGGGAGGA-TGACCCTCTCGGCCCGG-3' (7210 to 7174); 5'-GGC-ACCCTGTCAGTCCGGAAATAACTGCAG-3' (7 175 to 7145); 5'-GGCACCCTGTCAGTCCCCAAATAACTGC-AG-3' (7175 to 7145*); 5'-CTGCAGCATTTGTTCCG-GAGGGGAAGGCGCGAGG-3' (7150 to 7117); and 5' -GAAGGCGCGAGGT T TCCGGGAAAGCAGCACC-GCCCC-3' (7128 to 793). The gel shift competition experiments were performed by the same procedure using 50 ± 300-fold-excess of the indicated double-stranded primer.
DNA-protein complexes were resolved on a 6% polyacrylamide gel made in 0.26TBE and run overnight at 150 V (48C).
DNAse I footprinting
DNAse I footprinting was performed as previously described (Plaza et al., 1995a) . The WT-PCRII vector was used to map the Ets binding sites. The footprinting probe was prepared by end-labeling the HindIII digested WT-PCRII plasmid with the Klenow fragment of DNA polymerase I (Boehringer-Mannheim, Germany) in the presence of [a- 32 P]dCTP and -dATP (50 mCi each). After a secondary restriction with XbaI the fragment was puri®ed from a 5% non-denaturing polyacrylamide gel. The endlabeled DNA probe (2 ng) was incubated at 208C for 1 h with approximately 5 mg of GST or GST-ERM 355 ± 510 fusion protein, and 1 mg of poly (dl : dC) in a 100 ml volume of 0.56DB buer (10 mM HEPES (pH 7.9) 30 mM KCl, 0.12 mM EDTA, 0.06 mM EGTA, 10% (v/v) glycerol, 1 mM dithiothreitol and 1 mM PMSF) containing 5 mM MgCl 2 and 2.5 mM CaCl 2 . Digestion was performed with 20 ng of DNAse I (BRL) for 30 s at 208C. The reaction was terminated by the addition of 30 ml of 50 mM EDTA and 0.5 mg/ml of proteinase K. After phenol-chloroform extraction the samples were precipitated twice with ethanol and analysed on 6% polyacrylamide sequencing gel before autoradiography.
